Drug intelligence / Profile preview

zhenyuan qingyan san

Development stage: Unknown
Lead developer: Zhejiang Kangde Pharmaceutical
Administration: Oral

Overview

Zhenyuan Qingyan San is a traditional Chinese medicine (TCM) formulation developed and manufactured by Zhejiang Kangde Pharmaceutical. It is primarily indicated for the treatment of various throat conditions, including acute and chronic pharyngitis, tonsillitis, and general sore throat. The medication is formulated as a powder (San) for oral administration. It is part of the company's 'Zhenyuan' product line, which often incorporates herbal ingredients such as American ginseng (Panax quinquefolius) and other botanical extracts known in TCM for their heat-clearing, detoxifying, and throat-soothing properties. The product is approved for marketing in China under the NMPA (National Medical Products Administration) regulatory framework.

Brand names: Zhenyuan
Other names: Qingyan San珍源清咽散

Beyond the preview

Go deeper on zhenyuan qingyan san.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zhenyuan qingyan san.

Explore the full profile